|
CD2AP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.74960104368938E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.05159997060889E-09 |
| Normal-vs-Stage2 |
9.53230000044769E-07 |
| Normal-vs-Stage3 |
2.15394369007527E-12 |
| Normal-vs-Stage4 |
1.26639809749918E-11 |
| Stage1-vs-Stage2 |
5.786800E-01 |
| Stage1-vs-Stage3 |
1.159330E-04 |
| Stage1-vs-Stage4 |
8.324300E-03 |
| Stage2-vs-Stage3 |
1.435240E-01 |
| Stage2-vs-Stage4 |
2.781200E-01 |
| Stage3-vs-Stage4 |
5.939400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.20450366031855E-11 |
| Normal-vs-AfricanAmerican |
1.89135999999479E-05 |
| Normal-vs-Asian |
7.987900E-04 |
| Caucasian-vs-AfricanAmerican |
8.018600E-01 |
| Caucasian-vs-Asian |
8.342600E-01 |
| AfricanAmerican-vs-Asian |
9.714400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.72629713144102E-11 |
| Normal-vs-Female |
1.08929998354768E-09 |
| Male-vs-Female |
1.966790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.96210000469321E-08 |
| Normal-vs-Age(41-60Yrs) |
1.07789999148622E-10 |
| Normal-vs-Age(61-80Yrs) |
2.05570005462619E-11 |
| Normal-vs-Age(81-100Yrs) |
1.26660015808966E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.575950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.984200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.097400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.501600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.562260E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.705810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.000610E-03 |
| Normal-vs-Grade 2 |
7.96900001542866E-09 |
| Normal-vs-Grade 3 |
5.99079674756808E-11 |
| Normal-vs-Grade 4 |
1.66533453693773E-14 |
| Grade 1-vs-Grade 2 |
1.568570E-01 |
| Grade 1-vs-Grade 3 |
2.071600E-02 |
| Grade 1-vs-Grade 4 |
3.562100E-04 |
| Grade 2-vs-Grade 3 |
4.964200E-02 |
| Grade 2-vs-Grade 4 |
1.68639999997833E-06 |
| Grade 3-vs-Grade 4 |
3.219100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.08910000018447E-07 |
| Normal-vs-ccB subtype |
1.69575464781246E-12 |
| ccA subtype-vs-ccB subtype |
1.382630E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.34940006022578E-10 |
| Normal-vs-N1 |
3.576900E-03 |
| N0-vs-N1 |
7.910600E-01 |
|
|
